PV Reporter

MPN Information and Research Hub

Medical scientists in Melbourne invent novel approach worldwide to Cure Leukemia

Combo Blood Cancer Treatment Attacking JAK2 Protein – A Possible Approach to Curing Leukemia Australian medical scientists have discovered a new approach which is regarded as the landmark to kill blood cancer cells for treating a large number of aggressive adult and childhood leukemia, Melbourne’s Peter MacCallum Cancer Centre said via the Friday’s media release. The report […]

Living Well with Myeloproliferative Neoplasms

MPN town meeting Andrew Schorr from Patient Power -November, 23, 2013 – MD Anderson Cancer Center – Houston, TX Growing research is leading to a new understanding of Myeloproliferative Neoplasms (MPNs), including Polycythemia Vera (PV), Essential Thrombocythemia (ET) and Primary Myelofibrosis (PMF).  Excitement is building among experts about new treatment options which are shaping up […]

Cancer Research & Treatment MPN Symposium 2013 Videos

7th International Patient Symposium on Myeloproliferative Neoplasms Click on the picture below for the VIDEOS from CR&T International Patient Symposium:             Index of Topics Covered and Presenters: New Concepts in Basic Biology of MPNs – John Crispino, PHD What is the Value of Epigenetic Therapy in MPN Treatment? – Ronald […]

Welcome to PV Reporter

PV Reporter was created to provide “easy access” to pertinent information on Polycythemia Vera (PV),  Essential Thrombocythemia (ET) and Myelofibrosis (MF).  These disorders are Myeloproliferative Neoplasms (MPNs), a closely related group of blood cancers where the bone marrow cells that produce the body’s blood cells function and develop abnormally.

Learn More

Welcome to PV Reporter

PV Reporter is a trusted, patient-founded resource hub for the global myeloproliferative neoplasm (MPN) community, covering polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF). Founded by a PV patient in long-term molecular remission, PV Reporter translates the latest MPN research and FDA treatment news into clear, patient-friendly information you can actually use. We feature patient stories from people living with these blood cancers, video interviews with leading MPN specialists from major cancer centers, and plain-language coverage of breakthroughs in JAK2-driven disease, interferon therapy, and emerging clinical research.

PV Reporter is also home to the only doctor-vetted MPN Specialist Directory in the industry, helping patients connect with hematologists who truly understand MPNs, and a free MPN Clinical Trial Finder that requires no personal information so you can explore new treatment options on your own terms. Whether you were newly diagnosed or have lived with an MPN for years, PV Reporter is here to help you become an empowered, informed patient advocate.

MPN News

Join Our Newsletter!

Sponsorship Opportunities
Medical Dislaimer
Privacy Policy
Advertisers

About

PV Reporter was founded by David Wallace, a polycythemia vera (PV) patient since 2009 and now in remission for over six years. His diagnosis became a catalyst for learning and advocacy. Today, David is a dedicated patient advocate, author, and founder of MPN Cancer Connection. PV Reporter serves as a resource hub, sharing information, insights and fostering support for the global myeloproliferative neoplasm (MPN) community.

error: